• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Bavarian Nordic A/S (OP: BVNKF )

    27.08 UNCHANGED
    Streaming Delayed Price Updated: 10:43 AM EST, Dec 20, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 20
    Open 27.08
    Bid (Size) N/A (0)
    Ask (Size) N/A (0)
    Prev. Close 27.08
    Today's Range 27.08 - 27.08
    52wk Range 18.72 - 46.05
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    UK Secures Additional Doses Of Bavarian Nordic Mpox Vaccine To Combat New Variant Threat
    The UK government has purchased 150,000 mpox vaccine doses from Bavarian Nordic, enhancing its response to clade I mpox, while partnering with WHO and UNICEF. 
    Via Benzinga
    Moderna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows
    Moderna is conducting a Phase 1/2 trial of mRNA-1769, a potential mpox vaccine for adults. Early research shows it may outperform Bavarian Nordic's Jynneos in reducing severe disease in monkeys. 
    Via Benzinga

    Performance

    YTD
    +9.45%
    +9.45%
    1 Month
    -1.15%
    -1.15%
    3 Month
    -23.56%
    -23.56%
    6 Month
    +17.31%
    +17.31%
    1 Year
    +4.14%
    +4.14%

    More News

    Read More
    Mpox Vaccines: Challenges Persist as Congo Receives First Batch Of Doses Almost 2 Years After It Declared Epidemic
    Via Benzinga
    Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain
    Via Benzinga
    Mpox Vaccine Maker Bavarian Nordic Targets Broader Access With European Submission For Imvanex Adolescent Use During WHO Emergency
    Via Benzinga
    Bavarian Nordic Recruits US Firm For Packaging Services For Its Monkeypox Vaccine
    Via Benzinga
    Bavarian Nordic's Monkeypox Vaccine Gets Thumbs Up From EU Regulator
    Via Benzinga
    Monkeypox Vaccine Maker Bavarian Nordic Bets $380M On Emergent Bio's Travel Vaccines
    Via Benzinga
    West Africa-Based Studies Show JNJ, Merck's Ebola Vaccines Provide Lasting Antibodies
    Via Benzinga
    Threats For New Outbreak Looms, As Scientists Signal Deadly Monkeypox Variant Circulating In Central Africa
    Via Benzinga
    White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox
    Via Benzinga
    Is Monkeypox Outbreak Cooling? Health Officials Says Virus Transmission Has Slowed
    Via Benzinga
    SIGA Tech Made The Smallpox Treatment As Post-9/11 Bioterrorism Defense: Report
    Via Benzinga
    Bavarian Nordic Making All Efforts To Stretch Capacity To Boost Monkeypox Vaccine Supplies
    Via Benzinga
    Experts Cast Doubt On Dependence On Monkeypox Vaccine Amid Limited Trial Data, Supply Crunch
    Via Benzinga
    Applied DNA Seeks Approval For PCR-Based Monkeypox Virus Test
    Via Benzinga
    Biden Officials Seek To Boost Supply For Monkeypox Vaccines, Treatment
    Via Benzinga
    WeTrade Shares Soar On Collaboration Over Exclusive COVID-19 Omicron Disinfectant
    Via Benzinga
    A Biopharma Working On Malaria, Norovirus Vaccines Threw It's Hat In The Monkeypox Ring
    Via Benzinga
    Benzinga Before The Bell: More Amazon Workers Join Union Over Pay and Work Conditions, UK Inflation Highest In 40 Years, Sole Monkeypox Vaccine Maker Finds It Difficult To Meet Accelerating Demand And Other Top Financial Stories Wednesday, August 17
    Via Benzinga
    The Only Monkeypox Vaccine Maker Finds It Difficult To Meet Accelerating Demand
    Via Benzinga
    Bavarian Nordic's Monkeypox Vaccine Scores EU Approval As WHO Declares Global Health Emergency
    Via Benzinga
    The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings
    Via Benzinga
    Bavarian Nordic Inks Multiple Supply Pact For Its Monkey pox Vaccine, Updates FY22 Guidance
    Via Benzinga
    Bavarian Nordic Launches COVID-19 Booster Study To Compare Against Pfizer/BioNTech Shot
    Via Benzinga
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.